Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

Terminated

Conditions: Retinal Artery Occlusion
Age-related Macular Degeneration
Hypertensive Retinopathy
Diabetic Retinopathy
Retinal Vein Occlusion

Interventions: Procedure: Phase variance optical coherence tomography (PV-OCT)

First Posted Date: 2012-10-31

Last Posted Date: 2014-09-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT01717937

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Antimalarial Pharmacology in Children and Pregnant Women in Uganda

Completed

Conditions: Malaria
HIV

First Posted Date: 2012-10-31

Last Posted Date: 2024-10-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 473

Registration Number: NCT01717885

Locations: 🇺🇬
IDRC- Tororo Research Clinic and Tororo District Hospital, Tororo, Uganda

UCSF Research Participant Registry

Terminated

Conditions: Any Disease or Condition
Healthy

First Posted Date: 2012-10-30

Last Posted Date: 2015-03-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1541

Registration Number: NCT01717378

Locations: 🇺🇸
Clinical & Translational Science Institute, University of California San Francisco, San Francisco, California, United States

A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics

Phase 2

Completed

Conditions: Diabetes Type II

Interventions: Behavioral: Low Carbohydrate Diet
Behavioral: American Diabetes Association Diet
Behavioral: Mindfulness and Positive Affect Skills

First Posted Date: 2012-10-25

Last Posted Date: 2013-12-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 34

Registration Number: NCT01713764

Locations: 🇺🇸
Osher Center for Integrative Medicine, San Francisco, California, United States

Focal Ablation of Cervical Precancer

Not Applicable

Completed

Conditions: High-grade Cervical Intraepithelial Neoplasia

Interventions: Procedure: Focal treatment

First Posted Date: 2012-10-18

Last Posted Date: 2018-02-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT01709773

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

PET/CT of Skeletal Muscle Amino Acid Kinetics

Completed

Conditions: Sarcopenia

First Posted Date: 2012-10-03

Last Posted Date: 2015-01-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 12

Registration Number: NCT01698424

Locations: 🇺🇸
Imaging Center-Department of Radiology, UCSF, San Francisco, California, United States

iStart Smart for Teens for Healthy Weight Management

Not Applicable

Completed

Conditions: Overweight
Obese

Interventions: Behavioral: Pedometer
Behavioral: fitbit Ultra

First Posted Date: 2012-09-26

Last Posted Date: 2019-08-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT01693250

Locations: 🇺🇸
UCSF School of Nursing, San Francisco, California, United States

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes

Phase 4

Completed

Conditions: Bronchospasm, Exercise-Induced

Interventions: Drug: Placebo
Drug: ipratropium bromide

First Posted Date: 2012-09-24

Last Posted Date: 2020-06-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT01691079

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 2

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Temsirolimus

First Posted Date: 2012-09-19

Last Posted Date: 2020-12-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 29

Registration Number: NCT01687673

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States

Study of the Collaborative Life Skills Program

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder Symptoms

Interventions: Other: Business As Usual
Behavioral: Collaborative Life Skills Intervention (CLS)

First Posted Date: 2012-09-18

Last Posted Date: 2019-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 504

Registration Number: NCT01686724

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy